The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Acquired multicellular-mediated resistance to alkylating agents in cancer.
Open accessAbstract
EMT-6 murine mammary tumor sublines highly resistant to cyclophosphamide, cis-diamminedichloro-platinum(II), or N,N',N"-triethylenethiophosphoramide were generated in vivo by sequential treatment of tumor-bearing mice with the respective drugs. Previous studies demonstrated the drug-resistant phenotypes of the sublines were not expressed in vitro when the cells were grown as monolayer cultures. We now show that expression of drug resistance--including patterns of cross-drug resistance observed in vivo--can be fully recapitulated in vitro when the cells are grown under in vivo-like, three-dimensional conditions--namely, as multicellular tumor spheroids. Moreover, the spheroids generated from all of the drug-resistant sublines manifested a much more compact structure. Immediate drug-sensitivity testing of single cells released by trypsin treatment from compact drug-resistant spheroids revealed that such cells lost much of their drug-resistant properties. The results suggest a possible mechanism of acquired drug resistance in tumors based on the response of a cell population (i.e., multicellular or tissue resistance) as opposed to classic (uni)cellular resistance mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Li, M. L., Aggeler, J., Farson, D. A., Hatier, C., Hassell, J., & Bissell, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.136 · Cited by 619
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
Vascular and interstitial barriers to delivery of therapeutic agents in tumors
Jain, R. K. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046364 · Cited by 489
Multicellular spheroids: A review on cellular aggregates in cancer research
Mueller-Klieser, W. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00391431 · Cited by 434
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
Teicher, B., Herman, T., Holden, S., Wang, Y., Pfeffer, M., Crawford, J., & Frei, E. (1990) · Science · doi:10.1126/science.247.4949.1457 · Cited by 327
Self-citationResistance to adriamycin in multicellular spheroids
Sutherland, R. M., Eddy, H. A., Bareham, B., Reich, K., & Vanantwerp, D. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90643-6 · Cited by 225
(1984) · Recent Results in Cancer Research · doi:10.1007/978-3-642-82340-4 · Cited by 176
Multicellular oxidant defense in unicellular organisms.
Ma, M., & Eaton, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7924 · Cited by 137
Cited by
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
3D Cell Culture Systems: Advantages and Applications
Ravi, M., Paramesh, V., Kaviya, S. R., Anuradha, E., & Solomon, F. D. P. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24683 · Cited by 1,206
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Solid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793
Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis
Ivascu, A., & Kubbies, M. (2006) · SLAS Discovery · doi:10.1177/1087057106292763 · Cited by 597
Three-dimensional cell cultures: from molecular mechanisms to clinical applications
Mueller-Klieser, W. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.4.c1109 · Cited by 537
E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1
St. Croix, B., Sheehan, C., Rak, J. W., Flørenes, V. A., Slingerland, J. M., & Kerbel, R. S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.557 · Cited by 452
Self-citationA Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies
Elliott, N. T., & Yuan, F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22257 · Cited by 449
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Ying, X., Wen, H., Lu, W.-L., Du, J., Guo, J., Tian, W., Men, Y., Zhang, Y., Li, R.-J., Yang, T.-Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 447
The tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Shield, K., Ackland, M. L., Ahmed, N., & Rice, G. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.11.032 · Cited by 412
Multicellular resistance: a paradigm for clinical resistance?
Desoize, B. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00086-x · Cited by 400
Hickman, J. A., Graeser, R., de Hoogt, R., Vidic, S., Brito, C., Gutekunst, M., van der Kuip, H., & IMI PREDECT consortium (2014) · Biotechnology Journal · doi:10.1002/biot.201300492 · Cited by 380
Drug resistance in metastatic castration-resistant prostate cancer
Seruga, B., Ocana, A., & Tannock, I. F. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.136 · Cited by 336
Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology
KUNZ‐SCHUGHART, L. A., KREUTZ, M., & KNUECHEL, R. (1998) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1998.00051.x · Cited by 324
Croix, B. S., Flørenes, V. A., Rak, J. W., Flanagan, M., Bhattacharya, N., Slingerland, J. M., & Kerbel, R. S. (1996) · Nature Medicine · doi:10.1038/nm1196-1204 · Cited by 322
Self-citationXu, Z., Gao, Y., Hao, Y., Li, E., Wang, Y., Zhang, J., Wang, W., Gao, Z., & Wang, Q. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.045 · Cited by 295
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280
Drug and radiation resistance in spheroids: cell contact and kinetics
Olive, P. L., & Durand, R. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689632 · Cited by 270
Three-Dimensional Spheroid Model in Tumor Biology
Santini, M. T., & Rainaldi, G. (1999) · Pathobiology · doi:10.1159/000028065 · Cited by 265
Zhang, X., Fryknäs, M., Hernlund, E., Fayad, W., De Milito, A., Olofsson, M. H., Gogvadze, V., Dang, L., Påhlman, S., Schughart, L. A. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms4295 · Cited by 253
Stock, K., Estrada, M. F., Vidic, S., Gjerde, K., Rudisch, A., Santo, V. E., Barbier, M., Blom, S., Arundkar, S. C., Selvam, I., et al. (2016) · Scientific Reports · doi:10.1038/srep28951 · Cited by 253
Costa, E. C., de Melo‐Diogo, D., Moreira, A. F., Carvalho, M. P., & Correia, I. J. (2018) · Biotechnology Journal · doi:10.1002/biot.201700417 · Cited by 224
Hongisto, V., Jernström, S., Fey, V., Mpindi, J.-P., Kleivi Sahlberg, K., Kallioniemi, O., & Perälä, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077232 · Cited by 181
“Threedimensional culture models have also been indicated to better mimic in vivo situations by others; EMT-6 mammary tumor cells are highly resistant to alkylating agents in vivo and lose their resistance in traditional 2D monolayers as opposed to 3D cultures [37].”
BackgroundL'Espérance, S., Bachvarova, M., Tetu, B., Mes-Masson, A.-M., & Bachvarov, D. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-99 · Cited by 108
Lemmo, S., Atefi, E., Luker, G. D., & Tavana, H. (2014) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-014-0349-4 · Cited by 71
Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines
Lai, Y., Asthana, A., & Kisaalita, W. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.01.009 · Cited by 43
Solomon, M. A., Shah, A. A., & D'Souza, G. G. M. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.10.013 · Cited by 39
Metadata
- Authors
- Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., & Kerbel, R. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-04-15
- Volume
- 90
- Issue
- 8
- Pages
- 3294-3298
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023300542
- Cited by
- 278
- References
- 22
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.